$0.48 EPS Expected for Acadia Healthcare (ACHC) This Quarter

Wall Street brokerages forecast that Acadia Healthcare (NASDAQ:ACHC) will post earnings of $0.48 per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Acadia Healthcare’s earnings, with estimates ranging from $0.47 to $0.48. Acadia Healthcare posted earnings per share of $0.46 in the same quarter last year, which would suggest a positive year over year growth rate of 4.3%. The firm is scheduled to issue its next earnings results after the market closes on Tuesday, May 1st.

According to Zacks, analysts expect that Acadia Healthcare will report full-year earnings of $2.46 per share for the current fiscal year, with EPS estimates ranging from $2.42 to $2.50. For the next year, analysts anticipate that the business will post earnings of $2.77 per share, with EPS estimates ranging from $2.63 to $2.92. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that that provide coverage for Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, February 21st. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Acadia Healthcare had a net margin of 6.92% and a return on equity of 8.16%. The business had revenue of $724.50 million during the quarter, compared to analysts’ expectations of $713.20 million. During the same quarter in the previous year, the company earned $0.59 EPS. The business’s revenue was up 3.1% on a year-over-year basis.



Several analysts have weighed in on the stock. BidaskClub cut shares of Acadia Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Tuesday. BMO Capital Markets reiterated an “outperform” rating and issued a $45.00 price objective (up previously from $40.00) on shares of Acadia Healthcare in a research note on Friday, February 23rd. ValuEngine cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Saturday, April 7th. Wells Fargo initiated coverage on shares of Acadia Healthcare in a research note on Tuesday, January 30th. They issued an “outperform” rating and a $41.00 price objective for the company. Finally, Credit Suisse Group restated a “neutral” rating and issued a $40.00 target price (up from $35.00) on shares of Acadia Healthcare in a research report on Thursday, February 22nd. One analyst has rated the stock with a sell rating, six have issued a hold rating and twelve have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $44.50.

Acadia Healthcare stock traded down $1.18 during midday trading on Friday, hitting $37.98. The company’s stock had a trading volume of 706,029 shares, compared to its average volume of 891,035. Acadia Healthcare has a 1-year low of $26.92 and a 1-year high of $54.34. The company has a quick ratio of 1.25, a current ratio of 1.25 and a debt-to-equity ratio of 1.25. The stock has a market capitalization of $3,456.77, a price-to-earnings ratio of 16.51, a price-to-earnings-growth ratio of 1.28 and a beta of 0.63.

In related news, VP Randall P. Goldberg sold 960 shares of Acadia Healthcare stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $38.47, for a total transaction of $36,931.20. Following the sale, the vice president now directly owns 6,942 shares of the company’s stock, valued at approximately $267,058.74. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Reeve B. Waud sold 200,000 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, March 6th. The shares were sold at an average price of $39.02, for a total transaction of $7,804,000.00. Following the sale, the director now directly owns 10,088 shares in the company, valued at $393,633.76. The disclosure for this sale can be found here. Insiders sold a total of 401,360 shares of company stock valued at $15,759,096 over the last 90 days. Corporate insiders own 11.10% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. State of Alaska Department of Revenue bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at approximately $150,000. Tyers Asset Management LLC grew its holdings in shares of Acadia Healthcare by 31.8% during the 4th quarter. Tyers Asset Management LLC now owns 5,904 shares of the company’s stock valued at $193,000 after purchasing an additional 1,424 shares during the last quarter. Xact Kapitalforvaltning AB bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at approximately $231,000. CIBC World Markets Inc. bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at approximately $236,000. Finally, Parametrica Management Ltd bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at approximately $327,000.

COPYRIGHT VIOLATION WARNING: This article was first published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://stocknewstimes.com/2018/04/21/0-48-eps-expected-for-acadia-healthcare-achc-this-quarter.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply